KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $4.1 billion.

  • Teva Pharmaceutical Industries' Treasury Shares changed 0.0% to $4.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $4.1 billion for FY2025, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Treasury Shares is $106.0 million, which was down 0.0% from $106.0 million recorded in Q2 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Treasury Shares peaked at $107.0 million during Q4 2024, and registered a low of $24.4 million during Q4 2021.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Treasury Shares value was $106.0 million (recorded in 2021), while the average stood at $94.2 million.
  • Over the last 5 years, Teva Pharmaceutical Industries' Treasury Shares had its largest YoY gain of 0.0% in 2021, and its largest YoY loss of 0.0% in 2021.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Treasury Shares stood at $4.1 billion in 2021, then changed by 0.0% to $4.1 billion in 2022, then changed by 0.0% to $4.1 billion in 2023, then changed by 0.0% to $4.1 billion in 2024, then changed by 0.0% to $4.1 billion in 2025.
  • Its Treasury Shares stands at $4.1 billion for Q4 2025, versus $4.1 billion for Q3 2025 and $4.1 billion for Q2 2025.